SILVER SPRING, Md., June 3, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic's ...

Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...

PLEASANTON, Calif. -- Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it has acquired the ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global ventricular assist devices market since 2015 and the market is poised to grow by USD 943.27 million during 2020-2024 at a CAGR of ...

FRAMINGHAM, Mass. and SYDNEY, Jan. 9, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies ...

(RTTNews) - Medical devices maker Medtronic plc (MDT) will stop the distribution and sale of the Medtronic Heartware Ventricular Assist Device (HVAD) System. It has also notified physicians to cease ...

BrioHealth Solutions announces it has reached a major milestone with the 100th enrollment in the INNOVATE Trial of the BrioVAD® System, a Left Ventricular Assist Device (LVAD). The BrioVAD® System ...

The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic's Heartware Ventricular Assist Device (HVAD) System due to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has designated Medtronic’s recall of two parts ...

The DuraHeart Left-Ventricular Assist System, or “LVAS,” from Terumo Heart was featured at a recent health technology event. DuraHeart LVAS is a next-generation medical device designed to help sustain ...

An “Urgent Medical Device Correction” issued by Abbott-Thoratec for its HeartMate II LVAS Pocket System Controller has been classified by the US Food and Drug Administration (FDA) as a class I recall, ...